Cascadian Therapeutics, Inc. (CASC) Files Form 4 Insider Buying : Scott Dunseth Myers Buys 62,500 Shares

Cascadian Therapeutics, Inc. (CASC): Scott Dunseth Myers , CEO of Cascadian Therapeutics, Inc. purchased 62,500 shares on Jun 28, 2016. The Insider buying transaction was reported by the company on Jun 28, 2016 to the Securities and Exchange Commission. The shares were purchased at $0.80 per share for a total value of $50,000.00 , the company said in a SEC Form 4 Filing.

Leave a Reply

Cascadian Therapeutics, Inc. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cascadian Therapeutics, Inc.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.